Keyphrases
Disease Burden
100%
Ablation
100%
NF-B
100%
Myeloproliferative Neoplasms
100%
Interleukin-1β
25%
Inflammatory Cytokines
25%
Patient-derived Xenograft
25%
Vulnerability
25%
Ablating
25%
Bone Marrow Fibrosis
25%
Conditional Knockout
25%
MicroRNA
25%
Syngeneic
25%
Leukemia
25%
Therapeutic Approaches
25%
Hyperactivity
25%
Negative Regulator
25%
Engraftment
25%
Myelofibrosis
25%
Polycythemia Vera
25%
Xenograft Mouse Model
25%
Multipotent Progenitors
25%
Myeloid Differentiation Factor 88 (MyD88)
25%
Pharmacological Targeting
25%
RelA
25%
JAK2V617F
25%
Oncogenic Signaling
25%
Emerging Therapeutics
25%
Signaling Effectors
25%
MiR-146a
25%
Early Lethality
25%
MPLW515L
25%
Pro-inflammation
25%
CA-4948
25%
Pharmacology, Toxicology and Pharmaceutical Science
Myeloproliferative Neoplasm
100%
Diseases
100%
Myelofibrosis
33%
Lethality
16%
Phosphotransferase
16%
Cytokine
16%
Mouse Model
16%
Interleukin 1
16%
Polycythemia vera
16%
microRNA
16%
Myeloid Differentiation Factor 88
16%
Carisoprodol
16%
microRNA 146a
16%
Biochemistry, Genetics and Molecular Biology
Disease Burden
100%
Mouse Model
25%
Kinase
25%
Phosphotransferase
25%
Interleukin-1
25%
MicroRNA
25%
Syngenic
25%
Inflammatory Cytokine
25%
RELA
25%
Carisoprodol
25%